Mallinckrodt subpoenaed by Justice Department on opioid products
August 03, 2017 at 08:33 AM EDT
Mallinckrodt Pharmaceuticals said Wednesday it received a subpoena July 27 from the U.S. Department of Justice seeking information on its promotional practices for, and sales of, opioid products it makes, markets or sells.
